Skip to content
healthcare.dev

zonisamide

NDC 69097-861, zonisamide, capsule, from Cipla USA Inc..

Product NDC
69097-861
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077869
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-861 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZONISAMIDE100 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; P-Glycoprotein Inhibitors [MoA]; Sulfonamides [CS]

Package NDCNDC-11Package
69097-861-0769097086107100 CAPSULE in 1 BOTTLE (69097-861-07)
69097-861-1269097086112500 CAPSULE in 1 BOTTLE (69097-861-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e8f368cb-6a07-4178-95fa-1d5a209171ed
  • NADAC price for package 69097086107

    GET /v1/drugs/nadac/69097086107

Use it

Look up 69097-861 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-861 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-861. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.